the role of inflammatory signaling pathways in lower-risk mds
Published 1 year ago • 60 plays • Length 1:59Download video MP4
Download video MP3
Similar videos
-
3:06
the role of chronic inflammation in lower-risk mds and future therapeutic strategies
-
3:19
inflammatory signaling in the pathogenesis of mds
-
2:06
understanding the role of inflammation and the immunome in mds pathophysiology
-
1:32
the role of the innate immune system in mds pathogenesis
-
1:37
the role of the innate immune system in mds & the value of targeting immune signaling pathways
-
2:49
the role of the immune system in the pathophysiology of mds
-
1:41
an overview of the mds diagnosis pathway
-
0:55
the role of rna modifications in mds and aml
-
7:54
patient/caregiver stories - living with mds
-
4:48
managing and treating mds
-
11:53
the optimal treatment of lower risk mds
-
1:39
the mechanism of action of navtemadlin and its role in mf
-
1:51
factors driving the transformation of chip to mds
-
6:05
the immune system's role in higher-risk mds
-
1:18
incorporating genetic analyses in the diagnostic pathway of mds
-
2:00
genetic mutations and inflammation: understanding the links and improving prognosis in mds
-
1:34
sequencing of agents in lr-mds
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
1:16
state of the art: mds
-
3:10
the role of ngs in mds diagnosis
-
1:52
advances in lr-mds and hr-mds in 2023 and beyond
-
1:32
next-generation sequencing for low-risk mds